AbbVie Botox Cosmetic — Net revenues increased by 12.6% to $717.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $687.00M to $717.00M. Over 4 years (FY 2021 to FY 2025), Botox Cosmetic — Net revenues shows an upward trend with a 3.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong consumer demand and successful market adoption of aesthetic treatments, while a decrease may signal increased competition or shifting consumer spending patterns.
This metric represents the total gross sales of the Botox Cosmetic product line after accounting for returns, allowances...
Comparable to revenue reporting for specific high-growth aesthetic or consumer-facing pharmaceutical product lines at peer companies in the medical aesthetics sector.
abbv_segment_botox_cosmetic_net_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $584.00M | $545.00M | $626.00M | $641.00M | $695.00M | $637.00M | $642.00M | $659.00M | $685.00M | $620.00M | $718.00M | $633.00M | $729.00M | $671.00M | $687.00M | $556.00M | $692.00M | $637.00M | $717.00M |
| QoQ Change | — | -6.7% | +14.9% | +2.4% | +8.4% | -8.3% | +0.8% | +2.6% | +3.9% | -9.5% | +15.8% | -11.8% | +15.2% | -8.0% | +2.4% | -19.1% | +24.5% | -7.9% | +12.6% |
| YoY Change | — | — | — | — | +19.0% | +16.9% | +2.6% | +2.8% | -1.4% | -2.7% | +11.8% | -3.9% | +6.4% | +8.2% | -4.3% | -12.2% | -5.1% | -5.1% | +4.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.